Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Narendran

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsW Gordon Frankle, Mark Slifstein, Roger N Gunn, et al.
Plos One|March 3, 2012
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levelsW Gordon Frankle, Raymond Y Cho, N Scott Mason, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
The American Journal of Psychiatry|July 3, 2015
In vivo measurement of GABA transmission in healthy subjects and schizophrenia patientsW Gordon Frankle, Raymond Y Cho, Konasale M Prasad, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2005
Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomographyBart N M van Berckel, Lawrence S Kegeles, Rikki Waterhouse, et al.
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
Molecular Imaging and Biology|March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primatesDah-Ren Hwang, Rajesh Narendran, Yiyun Huang, et al.
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsW Gordon Frankle, Mark Slifstein, Roger N Gunn, et al.
Plos One|March 3, 2012
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levelsW Gordon Frankle, Raymond Y Cho, N Scott Mason, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
The American Journal of Psychiatry|July 3, 2015
In vivo measurement of GABA transmission in healthy subjects and schizophrenia patientsW Gordon Frankle, Raymond Y Cho, Konasale M Prasad, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 24, 2005
Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomographyBart N M van Berckel, Lawrence S Kegeles, Rikki Waterhouse, et al.
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
Molecular Imaging and Biology|March 3, 2011
Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ)Charles M Laymon, Rajesh Narendran, Neale S Mason, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2004
Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primatesDah-Ren Hwang, Rajesh Narendran, Yiyun Huang, et al.
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Pageof 7